APA (7th ed.) Citation

Shi, C., Zhang, Q., Li, Y., Zhao, J., Wang, C., & Zhang, Y. Polyethylene glycol loxenatide protects diabetic kidneys by inhibiting GRP78/PERK/eIF2α pathway, and improves cardiac injury by suppressing TLR4/NF-κB inflammatory pathway. BMC.

Chicago Style (17th ed.) Citation

Shi, Chen, Qilin Zhang, Yufeng Li, Junjun Zhao, Cong Wang, and Yu Zhang. Polyethylene Glycol Loxenatide Protects Diabetic Kidneys by Inhibiting GRP78/PERK/eIF2α Pathway, and Improves Cardiac Injury by Suppressing TLR4/NF-κB Inflammatory Pathway. BMC.

MLA (9th ed.) Citation

Shi, Chen, et al. Polyethylene Glycol Loxenatide Protects Diabetic Kidneys by Inhibiting GRP78/PERK/eIF2α Pathway, and Improves Cardiac Injury by Suppressing TLR4/NF-κB Inflammatory Pathway. BMC.